HEAL Initiative-Early-Stage Discovery of New Pain Targets Within the Understudied Druggable Proteome (R03 Clinical Trial Not Allowed)
This grant funds early-stage discovery research focused on identifying new pain targets within the understudied druggable proteome.
About this program
The HEAL Initiative aims to accelerate scientific solutions to stem the national opioid public health crisis. This specific grant opportunity supports early-stage discovery research that seeks to identify new pain targets within the understudied druggable proteome. It is designed for researchers who are exploring innovative approaches to pain management and treatment. The initiative encourages the development of novel therapeutic strategies that can lead to effective pain relief without the risks associated with opioid use. Eligible applicants include academic institutions, nonprofit organizations, and other research entities that have the capacity to conduct biomedical research. The grant is intended for projects that can contribute significantly to the understanding of pain mechanisms and the development of new pain therapies. By focusing on the druggable proteome, the initiative seeks to uncover new biological pathways and targets that can be exploited for drug development, ultimately aiming to improve patient outcomes in pain management.
Eligibility
Eligible applicants include academic institutions, nonprofit organizations, and other research entities capable of conducting biomedical research.